Body

Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence

Study finds women with triple negative breast cancer and BRCA mutations have lower risk of recurrence

Phase II study finds tanezumab reduces osteoarthritis knee pain

(SACRAMENTO, Calif.) — Just months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee, the results of a small, phase II clinical trial found only a few minor side effects and substantial improvement in patient conditions. The results of the 16-week study are published in the Sept. 30 issue of The New England Journal of Medicine.

Less chemotherapy works well for some childhood cancer

A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.

Researchers find first genetic evidence for loss of teeth in the common ancestor of baleen whales

RIVERSIDE, Calif. – In contrast to a toothed whale, which retains teeth that aid in capturing prey, a living baleen whale (e.g., blue whale, fin whale, humpback, bowhead) has lost its teeth and must sift zooplankton and small fish from ocean waters with baleen or whalebone, a sieve-like structure in the upper jaw that filters food from large mouthfuls of seawater.

Novel test following prostate surgery could detect cancer recurrence earlier

DENVER — A new test could reliably detect early increases in prostate specific antigen (PSA) levels — a biomarker commonly used to measure the recurrence of prostate cancer — in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes.

Data measuring the efficacy of this new test were presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

MicroRNA panel provides a more precise lung cancer diagnosis

DENVER — A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer.

Tina B. Edmonston, M.D., director of the clinical laboratory at Rosetta Genomics, Inc., presented data on the assay at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held here.

Screening tool can detect colorectal cancer from a small blood sample

DENVER — A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity.

"Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup," said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S.

Not just an innocent bystander

Severe sepsis, a disease characterised by a sudden drop in blood pressure and progressive organ dysfunction following infection, remains one of the most common causes of mortality in intensive care units worldwide. Even under the best possible medical conditions, mortality rates range between 30 and 70%. A research team from the Instituto Gulbenkian de Ciência, Portugal, led by Miguel Soares, found that free heme, released from red blood cells during infection, is the cause of organ failure, leading to the lethal outcome of severe sepsis.

California's leadership in tobacco control results in lower lung cancer rate

California's leadership in tobacco control results in lower lung cancer rate

A study led by researchers at the University of California, San Diego shows that California's 40 year-long tobacco control program has resulted in lung cancer rates that are nearly 25 percent lower than other states.

Less than half of essential workers willing to report to work during a serious pandemic

September 28, 2010 – Although first responders willingly put themselves in harm's way during disasters, new research indicates that they may not be as willing— if the disaster is a potentially lethal pandemic.

In a recent study, researchers at Columbia University's Mailman School of Public Health found that more than 50% of the first responders and other essential workers they surveyed might be absent from work during a serious pandemic, even if they were healthy.

New twists in double helix discovery story are uncovered

Cold Spring Harbor, NY -- The story of the double helix's discovery has a few new twists. A new primary source -- a never-before-read stack of letters to and from Francis Crick, and other historical materials dating from the years 1950-76 -- has been uncovered by two professors at the Watson School of Biological Sciences at Cold Spring Harbor Laboratory (CSHL).

Report casts world's rivers in 'crisis state'

MADISON — The world's rivers, the single largest renewable water resource for humans and a crucible of aquatic biodiversity, are in a crisis of ominous proportions, according to a new global analysis.

The report, published today (Sept. 30) in the journal Nature, is the first to simultaneously account for the effects of such things as pollution, dam building, agricultural runoff, the conversion of wetlands and the introduction of exotic species on the health of the world's rivers.

Global study finds widespread threats to world's rivers

Multiple environmental stressors, such as agricultural runoff, pollution and invasive species, threaten rivers that serve 80 percent of the world's population, around 5 billion people, according to researchers from The City College (CCNY) of The City University of New York (CUNY), University of Wisconsin and seven other institutions. These same stressors endanger the biodiversity of 65 percent of the world's river habitats and put thousands of aquatic wildlife species at risk.

Scientists stack up new genes for height

CHAPEL HILL – An international team of researchers, including a number from the University of North Carolina at Chapel Hill schools of medicine and public health, have discovered hundreds of genes that influence human height.

Their findings confirm that the combination of a large number of genes in any given individual, rather than a simple "tall" gene or "short" gene, helps to determine a person's stature. It also points the way to future studies exploring how these genes combine into biological pathways to impact human growth.

Research on killer HIV antibodies provides promising new ideas for vaccine design

New discoveries about the immune defenses of rare HIV patients who produce antibodies that prevent infection suggest a novel direction for designing new vaccines. Researchers at Rockefeller University and colleagues have now made two fundamental discoveries about the so called broadly neutralizing anti-HIV antibodies, which effectively keep the virus at bay. By detailing the molecular workings of a proven immune response, the researchers hope their work will ultimately enable them to similarly arm those who are not equipped with this exceptional immunological firepower.